UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 59

Sortiert nach

FDA Approval Summary: Entrectinib for the Treatment of NTRK gene Fusion Solid Tumors

Clinical cancer research, 2021-02, Vol.27 (4), p.928-932

2021

Volltextzugriff (PDF)

U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab

Clinical cancer research, 2017-07, Vol.23 (14), p.3484-3488

2017

Volltextzugriff (PDF)

FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer

Clinical cancer research, 2021-05, Vol.27 (9), p.2378-2382

2021

Volltextzugriff (PDF)

FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen

Clinical cancer research, 2017-12, Vol.23 (24), p.7448-7453

2017

Volltextzugriff (PDF)

FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma

Clinical cancer research, 2017-10, Vol.23 (19), p.5666-5670

2017

Volltextzugriff (PDF)

FDA Approval Summary: TAS-102

Clinical cancer research, 2017-06, Vol.23 (12), p.2924-2927

2017

Volltextzugriff (PDF)

FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With RET Gene Mutations or Fusions

Clinical cancer research, 2021-10, Vol.27 (20), p.5452-5456

2021

Volltextzugriff (PDF)

FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with RET Gene Mutations or Fusions

Clinical cancer research, 2021-04, Vol.27 (8), p.2130-2135

2021

Volltextzugriff (PDF)

FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC

Clinical cancer research, 2022-06, Vol.28 (11), p.2221-2228

2022

Volltextzugriff (PDF)

FDA Approval Summary: Selumetinib for Plexiform Neurofibroma

Clinical cancer research, 2021-08, Vol.27 (15), p.4142-4146

2021

Volltextzugriff (PDF)

Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells

Journal of leukocyte biology, 2007-08, Vol.82 (2), p.361-369

2007

Volltextzugriff (PDF)

Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells

The Journal of experimental medicine, 2009-02, Vol.206 (2), p.343-357

2009

Volltextzugriff (PDF)

Cytokine release: A workshop proceedings on the state-of-the-science, current challenges and future directions

Cytokine (Philadelphia, Pa.), 2016-09, Vol.85, p.101-108

2016

Volltextzugriff (PDF)

FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation

Clinical cancer research, 2014-10, Vol.20 (19), p.4994-5000

2014

Volltextzugriff (PDF)

Transforming growth factor-beta induces development of the T(H)17 lineage

Nature (London), 2006-05, Vol.441 (7090), p.231

2006

Volltextzugriff (PDF)

Transforming growth factor-β induces development of the TH17 lineage

Nature (London), 2006-05, Vol.441 (7090), p.231-234

2006

Volltextzugriff (PDF)

Gα13 Mediates a Signal That Is Essential for Proliferation and Survival of Thymocyte Progenitors

The Journal of experimental medicine, 2004-11, Vol.200 (10), p.1315-1324

2004

Volltextzugriff (PDF)

Development of Drugs for Pediatric Cancers

Pediatric Drug Development,2, 2013, p.438-452

2013

Volltextzugriff (PDF)

G alpha 13 Mediates a Signal That Is Essential for Proliferation and Survival of Thymocyte Progenitors

The Journal of experimental medicine, 2004-11, Vol.200 (10), p.1315-1324

2004

Volltextzugriff (PDF)

Transforming growth factor-beta induces development of the T sub(H)17 lineage

Nature, 2006-05, Vol.441 (7090), p.231-234

2006

Volltextzugriff (PDF)

Transforming growth factor-beta induces development of the TH7 lineage

Nature, 2006-05, Vol.441 (7090), p.231-234

2006

Volltextzugriff (PDF)

Transforming growth factor-[beta] induces development of the TH17 lineage

Nature (London), 2006-05, Vol.441 (7090), p.231-234

2006

Volltextzugriff (PDF)

Transforming growth factor-β induces development of the T H 17 lineage

Nature, 2006-05, Vol.441 (7090), p.231-234

2006

Volltextzugriff (PDF)

Effects of the Gα13 pathway on T cell development and activation

Helms, Whitney S

2005

Volltextzugriff (PDF)

1 – 25 von 59

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(54)

Publikationsform

Sprache

Englisch
(59)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(33)
Life Sciences & Biomedicine
(32)
Humans
(26)
Oncology
(18)
Female
(15)
United States
(14)
Drug Approval
(13)
Male
(13)
Middle Aged
(11)
Adult
(10)
Animals
(10)
United States Food And Drug Administration
(10)
Aged
(9)
Immunology
(8)
Biological And Medical Sciences
(6)
Cancer
(6)
Disease-Free Survival
(6)
Drug-Related Side Effects And Adverse Reactions - Pathology
(6)
Lung Neoplasms - Drug Therapy
(6)
Mutation
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

FDA Approval Summary: Entrectinib for the Treatment of NTRK gene Fusion Solid Tumors

U.S. FDA Approval Summary: Nivolumab for Treatment of Unresectable or Metastatic Melanoma Following Progression on Ipilimumab

FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer

FDA Approval Summary: Trabectedin for Unresectable or Metastatic Liposarcoma or Leiomyosarcoma Following an Anthracycline-Containing Regimen

FDA Approval Summary: Accelerated Approval of Pembrolizumab for Second-Line Treatment of Metastatic Melanoma

FDA Approval Summary: TAS-102

FDA Approval Summary: Pralsetinib for the Treatment of Lung and Thyroid Cancers With RET Gene Mutations or Fusions

FDA Approval Summary: Selpercatinib for the Treatment of Lung and Thyroid Cancers with RET Gene Mutations or Fusions

FDA Approval Summary: Capmatinib and Tepotinib for the Treatment of Metastatic NSCLC Harboring MET Exon 14 Skipping Mutations or Alterations

FDA Approval Summary: Pembrolizumab, Atezolizumab, and Cemiplimab-rwlc as Single Agents for First-Line Treatment of Advanced/Metastatic PD-L1-High NSCLC

FDA Approval Summary: Selumetinib for Plexiform Neurofibroma

Modulation of NFAT-dependent gene expression by the RhoA signaling pathway in T cells

Contrasting roles for all-trans retinoic acid in TGF-beta-mediated induction of Foxp3 and Il10 genes in developing regulatory T cells

Cytokine release: A workshop proceedings on the state-of-the-science, current challenges and future directions

FDA approval summary: vemurafenib for treatment of unresectable or metastatic melanoma with the BRAFV600E mutation

Transforming growth factor-beta induces development of the T(H)17 lineage

Transforming growth factor-β induces development of the TH17 lineage

Gα13 Mediates a Signal That Is Essential for Proliferation and Survival of Thymocyte Progenitors

Development of Drugs for Pediatric Cancers

G alpha 13 Mediates a Signal That Is Essential for Proliferation and Survival of Thymocyte Progenitors

Transforming growth factor-beta induces development of the T sub(H)17 lineage

Transforming growth factor-beta induces development of the TH7 lineage

Transforming growth factor-[beta] induces development of the TH17 lineage

Transforming growth factor-β induces development of the T H 17 lineage

Effects of the Gα13 pathway on T cell development and activation

Suchergebnisse filtern